Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 09-2012 | 09-2011 | 09-2010 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -946 | -1,109 | -54 | 0 | N/A |
| Depreciation Amortization | 294 | 134 | N/A | 0 | N/A |
| Accounts receivable | -11 | 0 | N/A | N/A | N/A |
| Other Working Capital | 102 | 35 | 2 | 0 | N/A |
| Other Operating Activity | 132 | 656 | 0 | 0 | 0 |
| Operating Cash Flow | $-430 | $-285 | $-53 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -163 | -281 | N/A | 0 | N/A |
| Investing Cash Flow | $-163 | $-281 | $0 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 28 | N/A | N/A |
| Other Financing Activity | 719 | 545 | 38 | 0 | 0 |
| Financing Cash Flow | $719 | $545 | $66 | $0 | $N/A |
| Beginning Cash Position | 1 | 22 | 9 | 0 | N/A |
| End Cash Position | 128 | 1 | 22 | 0 | N/A |
| Net Cash Flow | $126 | $-21 | $13 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -430 | -285 | -53 | 0 | N/A |
| Capital Expenditure | -163 | -281 | 0 | N/A | N/A |
| Free Cash Flow | -593 | -566 | -53 | 0 | 0 |